Surrozen was founded in 2013 with a mission to develop innovative therapies to treat debilitating patient conditions. The company raised a series A round of investment in March of 2014 and has since established a presence in the Bay Area. Over the past four years, the company has attracted significant scientific, clinical and healthcare partners while reaching several key milestones.
